Insulet Corp. (PODD)
246.61
-4.89
(-1.94%)
USD |
NASDAQ |
Feb 27, 16:00
244.66
-1.95
(-0.79%)
Pre-Market: 08:38
Insulet EPS Diluted (Quarterly) : 1.441 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 1.030 |
| Intuitive Surgical, Inc. | 2.205 |
| Tandem Diabetes Care, Inc. | -0.0087 |
| Boston Scientific Corp. | 0.4493 |
| Stryker Corp. | 2.197 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 101.60M |
| Revenue (Quarterly) | 783.80M |
| Total Expenses (Quarterly) | 682.20M |
| Enterprise Value | 17.65B |
| Gross Profit Margin (Quarterly) | 72.76% |
| Profit Margin (Quarterly) | 12.96% |
| Earnings Yield | 1.42% |
| Operating Earnings Yield | 2.69% |
| Normalized Earnings Yield | 1.897 |